App-Quantinova.ai

Intravascular Near Infrared Fluorescence Molecular Imaging Identifies Macrophages in vivo in Thrombosis-Prone Plaques

Tetsuya Hara - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

histamine

Percutaneous Coronary Intervention and Dual Antiplatelet Therapy Are Safe Prior to Kidney Transplantation

Gagan Singh - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Incidence and Predictors of Recurrent Stent Thrombosis: Analysis of a Multicenter Stent Thrombosis Registry

Ehrin Armstrong - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

One-Year Clinical Outcomes With Biodegradable Polymer Biolimus-Eluting Stent in Patients With Diabetes Mellitus: Comparison With Durable Polymer Everolimus-Eluting Stent

Shoichi Kuramitsu - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

The Impact of Drug-eluting Stent Induced Coronary Endothelial Dysfunction on Neointimal Hyperplasia 9 Months After Stent Implantation

Kenichi Fujii - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Acetylcholine

Surrogate and Clinical Outcomes Following Ischemic Postconditioning During Primary Percutaneous Coronary Intervention of ST-segment Elevation Myocardial Infarction: A Meta-analysis of 17 Randomized Trials

Vishal Patel - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Impact of Prehospital Administration of Antithrombotic Medications on Infarct-related Artery Patency in ST-elevation Myocardial Infarction: Results from the FAST-MI 2010 Registry

Yves Cottin - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Bivalirudin versus Heparin in Patients with Acute Myocardial Infarction: A Meta-analysis of Randomized Trials

Paolo Pagnotta - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Association of Lipid Core Plaque as Detected by Coronary Near-infrared Spectroscopy With Short- and Long-term Outcomes After Cardiac Catheterization

Vishal G Patel - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Smooth Muscle Cell Specific Tsc1 Mediate Arterial Thrombosis And Arterial Injury

Yong-Joo Ahn - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Rapacan

Calcific Uremic Arteriolopathy is Characterized by Increased Arteriolar Bone Morphogenetic Protein Signaling

Sagar U Nigwekar - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Platelet-derived Endothelial Cell Growth Factor Participates in Platelet Signaling and Promotes Thrombosis

Alba Gigante - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ribose

Prognostic Impacts, Predictors and Genetic Determinants of High On-treatment Platelet Reactivity to Aspirin and Clopidogrel and in Patients Undergoing Elective PCI in Japanese Population

Taiki Sat - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Deletion of Tissue Factor Pathway Inhibitor in Zebrafish Leads to Enhanced Thrombosis, Atherosclerosis, and Myocardial Infarction Injury

Karl J Clark - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Angulation Range of Coronary Artery During the Cardiac Cycles is a Key Factor Inducing Stent Fracture; Demonstration by an in vitro Accelerated Durability Test

Jun Arai - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Promus Element

Safety and Efficacy of Triple versus Dual Anti-Platelet Therapy after Stent Implantation in Patients Requiring Chronic Anticoagulation: a Meta-analysis of Observational Studies

Ashwin Sawant - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Warfarin

Mechanical Circulatory Support for Failing Systemic Right Ventricle - A Viable Bridging Strategy to Transplant?

John -Sullivan - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Immobilised apoA-I and High-Density Lipoproteins are Anti-Thrombotic and Exert Anti-Inflammatory Effects in Vascular Smooth Muscle Cells

Joanne Tan - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Atrial Fibrillation: Possible Risk Factor of Senile Pulmonary Fibrosis?

Yifang Guo - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

A Thrombus-specific Drug Delivery System Using Biological Polymer Micelle Complex for the Treatment of Actively Forming Vascular Thromboembolism

Changsun Kang - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

Filters

7277 Abstracts